Literature DB >> 16903867

Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.

Niklas Beyersdorf1, Karen Balbach, Thomas Hünig, Thomas Kerkau.   

Abstract

T-cell receptor (TCR) stimulation is both central to homeostatic maintenance of CD4(+) CD25(+) regulatory T cells (T(reg) cells) in vivo and a prerequisite for the initiation of suppression by T(reg) cells, both in vivo and in vitro. However, TCR-independent stimulation of T(reg) cells, e.g. with superagonistic CD28-specific monoclonal antibodies (CD28-SA), not only expands these cells in vivo but, as we show here, also mediates large-scale expansion of rat T(reg) cells in vitro. Interestingly, CD28-SA stimulation plus interleukin (IL)-2 was even superior to conventional costimulation plus IL-2 in promoting T(reg) cell growth in vitro. Despite their highly activated phenotype suppression by T(reg) cells expanded in the absence of TCR stimulation remained fully dependent on TCR-triggering for initiation and cell contact was required to exert suppression. With regard to the regulation of suppression by CD28 stimulation we observed that neither the presence of a conventional anti-CD28 monoclonal antibody nor a CD28-SA generally rendered conventional T cells resistant to suppression by preactivated T(reg) cells. Taken together, we provide a novel protocol for long-term propagation of T(reg) cells in vitro and our data are the first to reveal a difference in the signals required for activation and expansion of T(reg) cells and those, involving the TCR, necessary for the initiation of suppression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903867      PMCID: PMC2265815          DOI: 10.1111/j.1365-2567.2006.02455.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

1.  Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific.

Authors:  A M Thornton; E M Shevach
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

Review 3.  Animal models of autoimmunity and their relevance to human diseases.

Authors:  S Sakaguchi
Journal:  Curr Opin Immunol       Date:  2000-12       Impact factor: 7.486

4.  Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

Authors:  H L Weiner
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

5.  The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Authors:  Patricia A Taylor; Christopher J Lees; Bruce R Blazar
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

6.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

Authors:  B Salomon; D J Lenschow; L Rhee; N Ashourian; B Singh; A Sharpe; J A Bluestone
Journal:  Immunity       Date:  2000-04       Impact factor: 31.745

7.  The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.

Authors:  Sarah E Allan; Laura Passerini; Rosa Bacchetta; Natasha Crellin; Minyue Dai; Paul C Orban; Steven F Ziegler; Maria Grazia Roncarolo; Megan K Levings
Journal:  J Clin Invest       Date:  2005-10-06       Impact factor: 14.808

8.  Interleukin 2 signaling is required for CD4(+) regulatory T cell function.

Authors:  Gláucia C Furtado; Maria A Curotto de Lafaille; Nino Kutchukhidze; Juan J Lafaille
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

9.  Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.

Authors:  Helmut Jonuleit; Edgar Schmitt; Hacer Kakirman; Michael Stassen; Jürgen Knop; Alexander H Enk
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

10.  Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected].

Authors:  Detlef Dieckmann; Cord Henrik Bruett; Heidi Ploettner; Manfred Bernhard Lutz; Gerold Schuler
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  9 in total

1.  Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.

Authors:  Manisha Singh; Sreemanti Basu; Christina Camell; Jacob Couturier; Rodolfo J Nudelman; Miguel A Medina; John R Rodgers; Dorothy E Lewis
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

2.  Localized delivery of immunosuppressive regulatory T cells to peripheral nerve allografts promotes regeneration of branched segmental defects.

Authors:  Kelly C Santos Roballo; Subash Dhungana; Zhongliang Jiang; John Oakey; Jared S Bushman
Journal:  Biomaterials       Date:  2019-04-17       Impact factor: 12.479

Review 3.  Delivering safer immunotherapies for cancer.

Authors:  Lauren Milling; Yuan Zhang; Darrell J Irvine
Journal:  Adv Drug Deliv Rev       Date:  2017-05-22       Impact factor: 15.470

Review 4.  Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation?

Authors:  Vinodh Pillai; Nitin J Karandikar
Journal:  Immunol Lett       Date:  2007-09-29       Impact factor: 3.685

5.  Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.

Authors:  Xuehui He; Ruben L Smeets; Esther van Rijssen; Annemieke M H Boots; Irma Joosten; Hans J P M Koenen
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

Review 6.  Translational Approaches Targeting Ceramide Generation From Sphingomyelin in T Cells to Modulate Immunity in Humans.

Authors:  Claudia Hollmann; Teresa Wiese; Fabio Dennstädt; Julian Fink; Jürgen Schneider-Schaulies; Niklas Beyersdorf
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

7.  Pituitary adenylate cyclase activating peptide deficient mice exhibit impaired thymic and extrathymic regulatory T cell proliferation during EAE.

Authors:  Yossan-Var Tan; Catalina Abad; Yuqi Wang; Robert Lopez; James A Waschek
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

8.  Signaling signatures and functional properties of anti-human CD28 superagonistic antibodies.

Authors:  Zoe Waibler; Linda Y Sender; Camilla Merten; Roland Hartig; Stefanie Kliche; Matthias Gunzer; Peter Reichardt; Ulrich Kalinke; Burkhart Schraven
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

9.  Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia.

Authors:  David Brea; Jesús Agulla; Manuel Rodríguez-Yáñez; David Barral; Pedro Ramos-Cabrer; Francisco Campos; Angeles Almeida; Antoni Dávalos; José Castillo
Journal:  J Cell Mol Med       Date:  2014-05-30       Impact factor: 5.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.